RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재후보 SCOPUS

      소화기계 감염 진료지침 권고안 = Clinical Guideline for the Diagnosis and Treatment of Gastrointestinal Infections

      한글로보기

      https://www.riss.kr/link?id=A103885049

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      There are many various diseases in the gastrointestinal infections, and we tried to make a diagnosis and treatment guideline for common diseases based on available diagnostic tools and antimicrobial susceptibility of major pathogens causing gastrointe...

      There are many various diseases in the gastrointestinal infections, and we tried to make a diagnosis and treatment guideline for common diseases based on available diagnostic tools and antimicrobial susceptibility of major pathogens causing gastrointestinal infections in our country. This guideline was developed by the committee of Korean Society for Chemotherapy, and covers infectious diarrhea, antibiotic associated diarrhea, enteric fever, hepatobiliary infection, and complicated intraabdominal infection.

      더보기

      참고문헌 (Reference)

      1 조덕곤, "흉선종의 흉막전이에 동반된 Group D Salmonella 농흉 및 심낭염 -1예 보고-" 대한흉부외과학회 37 (37): 382-385, 2004

      2 나병규, "화농성 간농양의 원인균 및 치료의 최근 변화" 대한간학회 9 (9): 275-283, 2003

      3 박혜선, "항생제 연관 설사의 치료" 대한소화기학회 54 (54): 5-12, 2009

      4 서태진, "최근 15년간 광주?전남지역에서 발생한 간농양의 임상적 고찰" 대한내과학회 68 (68): 26-38, 2005

      5 하 종, "최근 12년간의 화농성 간농양의 임상양상의 변화" 대한내과학회 74 (74): 37-50, 2008

      6 위성헌, "최근 10년간 화농성 간농양 141예의 임상적 특성 및 원인균의 항균제 감수성 양상" 대한감염학회 40 (40): 199-206, 2008

      7 김대원, "최근 10년간 간농양의 임상적 고찰" 대한내과학회 66 (66): 478-486, 2004

      8 김용희, "지역사회 및 병원 임상검체에서 분리한 대장균의 항생제 내성 양상" 한국미생물학회 42 (42): 252-256, 2006

      9 임현술, "우리나라 전염성 질환의 변화 양상" 대한예방의학회 38 (38): 117-124, 2005

      10 김대범, "시프로프록사신에 반응하지 않은 해외유입 장티푸스 3예" 대한내과학회 77 (77): 377-381, 2009

      1 조덕곤, "흉선종의 흉막전이에 동반된 Group D Salmonella 농흉 및 심낭염 -1예 보고-" 대한흉부외과학회 37 (37): 382-385, 2004

      2 나병규, "화농성 간농양의 원인균 및 치료의 최근 변화" 대한간학회 9 (9): 275-283, 2003

      3 박혜선, "항생제 연관 설사의 치료" 대한소화기학회 54 (54): 5-12, 2009

      4 서태진, "최근 15년간 광주?전남지역에서 발생한 간농양의 임상적 고찰" 대한내과학회 68 (68): 26-38, 2005

      5 하 종, "최근 12년간의 화농성 간농양의 임상양상의 변화" 대한내과학회 74 (74): 37-50, 2008

      6 위성헌, "최근 10년간 화농성 간농양 141예의 임상적 특성 및 원인균의 항균제 감수성 양상" 대한감염학회 40 (40): 199-206, 2008

      7 김대원, "최근 10년간 간농양의 임상적 고찰" 대한내과학회 66 (66): 478-486, 2004

      8 김용희, "지역사회 및 병원 임상검체에서 분리한 대장균의 항생제 내성 양상" 한국미생물학회 42 (42): 252-256, 2006

      9 임현술, "우리나라 전염성 질환의 변화 양상" 대한예방의학회 38 (38): 117-124, 2005

      10 김대범, "시프로프록사신에 반응하지 않은 해외유입 장티푸스 3예" 대한내과학회 77 (77): 377-381, 2009

      11 민영선, "성주군 S 초등학교 및 중학교에서 집단 발생한 세균성 이질에 관한 역학조사" 대한예방의학회 38 (38): 189-196, 2005

      12 조용균, "성인의 복잡성 복강내 감염증의 치료에서 Ertapenem 단독투여와 Ceftriaxone과Metronidazole 병용투여의 안전성과 유효성 평가를위한 다기관, 공개, 무작위, 비교 임상연구" 대한감염학회 37 (37): 330-336, 2005

      13 박은희, "설사환자에서 Campylobacter jejuni의 분리 및 항생제 감수성 특성" 한국생명과학회 17 (17): 811-815, 2007

      14 최정우, "살모넬라 간농양 1예" 대한소화기학회 47 (47): 316-319, 2006

      15 한상우, "대량의 각혈로 사망한 장티푸스 1예" 대한감염학회 36 (36): 326-329, 2004

      16 고상훈, "담낭염에 대한 임상적 고찰: 비결석성 담낭염과 결석성 담낭염의 비교" 대한외과학회 62 (62): 249-258, 2002

      17 전경만, "뇌수막염, 경추부 척추염 및 경막외 농양으로 발현한 장티푸스 균혈증 1예" 대한감염학회 35 (35): 53-56, 2003

      18 김지명, "급성담낭염 환자에서 경피적담낭조루술 시 담즙배양의 유용성과 배양양성 예측인자" 대한진단검사의학회 27 (27): 281-285, 2007

      19 김태현, "급성 췌장염의 내과적 치료" 대한내과학회 75 (75): 280-284, 2008

      20 황종운, "급성 간염으로 발현된 장티푸스 1예" 대한내과학회 75 (75): 77-81, 2008

      21 김준영, "국내에서 최초로 분리된 Shigella dysenteriae type 8에 의한 세균성 이질 환자 집단 발생" 대한임상미생물학회 8 (8): 153-159, 2005

      22 박상원, "국내 지역사회 3차 병원에서 최근 2년간 경험한 지역사회 균혈증의 원인과 예후에 관한 분석" 대한감염학회 37 (37): 255-264, 2005

      23 National Institute of Health, "국가적 항균제 내성 감시 현황" 14 : 273-283, 2003

      24 Reller ME, "Yield of stool culture with isolate toxin testing versus a twostep algorithm including stool toxin testing for detection of toxigenic Clostridium difficile" 45 : 3601-3605, 2007

      25 Marks MI, "Yersinia enterocolitic a gastroenteritis: a prospective study of clinical bacteriologic and epidemiologic features" 96 : 26-31, 1980

      26 World Health Organization, "World health report 2003: shaping the future" WHO 2003

      27 Farthing M, "World Gastroenterology Organisation practice guideline: Acute diarrhea"

      28 Lee KS, "Who are susceptible to pseudomembranous colitis among patients with presumed antibiotic-associated diarrhea?" 49 : 1552-1558, 2006

      29 Korea Centers for Disease Control and Prevention, "Water & foodborne diseases outbreaks in Korea, 2008" 2 : 584-590, 2009

      30 Sanchez J, "Virulence factors, pathogenesis and vaccine protection in cholera and ETEC diarrhea" 17 : 388-398, 2005

      31 Lee CK, "Usefulness of Widal test in the diagnosis of typhoid fever" 33 : 206-209, 2001

      32 Gotuzzo E, "Use of norfloxacin to treat chronic typhoid carriers" 157 : 1221-1225, 1988

      33 Van Allan RJ, "Uncomplicated amebic liver abscess: prospective evaluation of percutaneous therapeutic aspiration" 183 : 827-830, 1992

      34 Patel M, "USA300 genotype community-associated methicillinresistant Staphylococcus aureus as a cause of surgical site infections" 45 : 3431-3433, 2007

      35 Doria AS, "US or CT for diagnosis of appendicitis in children and adults? A meta-analysis" 241 : 83-94, 2006

      36 UK Working Party on Acute Pancreatitis, "UK guidelines for the management of acute pancreatitis" 54 : 1-9, 2005

      37 Parry CM, "Typhoid fever" 347 : 1770-1782, 2002

      38 Bhan MK, "Typhoid and paratyphoid fever" 366 : 749-762, 2005

      39 Donnelly MA, "Two nonadjacent regions in enteroaggregative Escherichia coli flagellin are required for activation of toll-like receptor 5" 277 : 40456-40461, 2002

      40 Das S, "Trend of antibiotic resistance of Vibrio cholerae strains from East Delhi" 127 : 478-482, 2008

      41 Punjabi NH, "Treatment of severe typhoid fever in children with high dose dexamethasone" 7 : 598-600, 1988

      42 Blessmann J, "Treatment of amoebic liver abscess with metronidazole alone or in combination with ultrasound-guided needle aspiration: a comparative, prospective and randomized study" 8 : 1030-1034, 2003

      43 Aslam S, "Treatment of Clostridium difficile associated disease: old therapies and new strategies" 5 : 549-557, 2005

      44 Rupali P, "Treatment failure in typhoid fever with ciprofloxacin susceptibile Salmonella enterica serotype Typhi" 49 : 1-3, 2004

      45 Tribble DR, "Traveler's diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen" 44 : 338-346, 2007

      46 Lyras D, "Toxin B is essential for virulence of Clostridium difficile" 458 : 1176-1179, 2009

      47 Allo MD, "Ticarcillin/clavulanate versus imipenem/cilistatin for the treatment of infections associated with gangrenous and perforated appendicitis" 65 : 99-104, 1999

      48 White NJ, "The treatment of typhoid fever" 9 : 298-302, 1996

      49 Ethelberg S, "The significance of the number of submitted samples and patient-related factors for faecal bacterial diagnostics" 13 : 1095-1099, 2007

      50 Seo S, "The serogroup and antimicrobial resistance of Salmonella spp. isolated from the clinical specimens during 6 years in a tertiary university hospital" 7 : 72-76, 2004

      51 Ratschko M, "The role of antibiotic prophylaxis in the treatment of acute pancreatitis" 28 : 641-659, 1999

      52 Yellin AE, "The role of Pseudomonas species in patients treated with ampicillin and Sulbactam for gangrenous and perforated appendicitis" 161 : 303-307, 1985

      53 Solomkin JS, "The role of Candida in intraperitoneal infections" 88 : 524-530, 1980

      54 Roehrborn A, "The microbiology of postoperative peritonitis" 33 : 1513-1519, 2001

      55 Duggan C, "The management of acute diarrhea in children: oral rehydration, maintenance, and nutritional therapy. Centers for Disease Control and Prevention" 41 : 1-20, 1992

      56 Ibrahim EH, "The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting" 118 : 146-155, 2000

      57 Maher MM, "The inaccessible or undrainable abscess: how to drain it" 24 : 717-735, 2004

      58 Kokoska ER, "The impact of intraoperative culture on treatment and outcome in children with perforated appendicitis" 34 : 749-753, 1999

      59 Yoo HM, "The changing patterns of liver abscess during the past 20 years: a study of 482 cases" 34 : 340-351, 1993

      60 Korea Centers for Disease Control and Prevention, "The analysis on the prevalence status and characteristics of bacterial pathogens causing acute diarrhea in Korea, 2007" 1 : 116-122, 2008

      61 Mazuski JE, "The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: evidence for the recommendations" Therapeutic Agents Committee of the Surgical Infections Society 3 : 175-233, 2002

      62 Mazuski JE, "The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal in fections: an executive summary" Therapeutic Agents Committee of the Surgical Infections Society 3 : 161-173, 2002

      63 태정현, "The First Case of Antibiotic-associated Colitis by Clostridium difficile PCR Ribotype 027 in Korea" 대한의학회 24 (24): 520-524, 2009

      64 Olson MM, "Ten years of prospective Clostridium difficile -associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991" 15 : 371-381, 1994

      65 Urban BA, "Targeted helical CT of the acute abdomen: appendicitis, diverticulitis, and small bowel obstruction" 21 : 20-39, 2000

      66 Jae In Lee, "Surveillance of Acute Gastroenteritis in Seoul, Korea, During May 2004 and June 2007" 대한미생물학회 39 (39): 363-371, 2009

      67 Wilton P, "Strategies to contain the emergence of antimicrobial resistance: a systematic review of effectiveness and cost-effectiveness" 7 : 111-117, 2002

      68 Marshall JC, "Source control in the management of severe sepsis and septic shock: an evidence-based review" 32 (32): S513-S526, 2004

      69 Zerem E, "Sonographically guided percutaneous cahtheter drainage versus needle aspiration in the management of pyogenic liver abscess" 189 : W138-W142, 2007

      70 Giannella RA, "Sleisenger & Fordtran's gastrointestinal and liver disease" Elsevier Saunders 2333-2391, 2006

      71 Rabbani GH, "Short-chain fatty acids improve clinical, pathologic, and microbiologic features of experimental shigellosis" 179 : 390-397, 1999

      72 Phalipon A, "Shigellosis: innate mechanisms of inflammatory destruction of the intestinal epithelium, adaptive immune response, and vaccine development" 23 : 371-401, 2003

      73 Lumsden A, "Secondary pancreatic infections" 170 : 459-467, 1990

      74 Guerrant RL, "Schwartzman JD. A cost effective and effective approach to the diagnosis and management of acute infectious diarrhea" 63 : 484-499, 1987

      75 Pai H, "Salmonella and Shigella infections in Infectious Diseases" Koonja 423-433, 2007

      76 Mourad FH, "Role of 5-hydroxytryptamine type 3 receptors in rat intestinal fluid and electrolyte secretion induced by cholera and Escherichia coli enterotoxins" 37 : 340-345, 1995

      77 Falagas ME, "Risk factors leading to clinical failure in the treatment of intraabdominal or skin/soft tissue infections" 15 : 913-921, 1996

      78 Jensen AG, "Risk factors for hospital-acquired Staphylococcus aureus bacteremia" 159 : 1437-1444, 1999

      79 Hosoglu S, "Risk factors for enteric perforation in patients with typhoid Fever" 160 : 46-50, 2004

      80 Wacha H, "Risk factors associated with intraabdominal infections: a prospective multicenter study" 384 : 24-32, 1999

      81 Ochoa TJ, "Rifaximin does not induce toxin production or phage-mediated lysis of Shiga toxin-producing Escherichia coli" 51 : 2837-2841, 2007

      82 Solomkin JS, "Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections" 223 : 303-315, 1996

      83 Solomkin JS, "Results of a clinical trial of clinafloxacin versus imipenem/cilastin for intraabdominal infections" 233 : 79-87, 2001

      84 노경호, "Resistance Trends of Bacteroides fragilis Group Over an 8-Year Period, 1997-2004, in Korea" 대한진단검사의학회 29 (29): 293-298, 2009

      85 Musher DM, "Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole" 40 : 1586-1590, 2005

      86 Koperna T, "Relaparotomy in peritonitis: prognosis and treatment of patients with persisting intraabdominal infection" 24 : 32-37, 2000

      87 Crump JA, "Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae" 37 : 75-81, 2003

      88 Hoffman SL, "Reduction of mortality in chloramphenicol-treated severe typhoid fever by high-dose dexamethasone" 310 : 82-88, 1984

      89 Hahn S, "Reduced osmolarity oral rehydration solution for treating dehydration due to diarrhoea in children: systematic review" 323 : 81-85, 2001

      90 Floch MH, "Recommendations for probiotic use--2008" 42 (42): S104-S108, 2008

      91 "Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practice Advisory Committee (HICPAC)" 44 : 1-13, 1995

      92 Townes JM, "Reactive arthritis following culture-confirmed infections with bacterial enteric pathogens in Minnesota and Oregon: a populationbased study" 67 : 1689-1696, 2008

      93 Sandhu BK, "Rationale for early feeding in childhood gastroenteritis" 33 (33): S13-S16, 2001

      94 Kim OS, "Rate of nasal colonization of methicillin-resistant Staphylococcus aureus at admission to a medical intensive care unit" 12 : 42-49, 2007

      95 Namias N, "Randomized, multicenter, double-blind study of efficacy, safety, and tolerability of intravenous ertapenem versus piperacillin/tazobactam in treatment of complicated intraabdominal infections in hospitalized adults" 8 : 15-28, 2007

      96 Malangoni MA, "Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections" 244 : 204-211, 2006

      97 Parry CM, "Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever" 51 : 819-825, 2007

      98 Gotuzzo E, "Quinolones in typhoid fever" 3 : 345-351, 1994

      99 Bhutta ZA, "Quinolone-resistant Salmonella paratyphi B meningitis in a newborn: a case report" 35 : 308-310, 1997

      100 Zhang X, "Quinolone antibiotics induce Shiga toxinencoding bacteriophages, toxin production, and death in mice" 181 : 664-670, 2000

      101 Giorgio A, "Pyogenic liver abscesses: 13 years of experience in percutaneous needle aspiration with US guidance" 195 : 122-124, 1995

      102 Ch Yu S, "Pyogenic liver abscess: treatment with needle aspiration" 52 : 912-916, 1997

      103 Rahimian J, "Pyogenic liver abscess: recent trends in etiology and mortality" 39 : 1654-1659, 2004

      104 Lok KH, "Pyogenic liver abscess: clinical profile, microbiological characteristics, and management in a Hong Kong hospital" 41 : 483-490, 2008

      105 Barakate MS, "Pyogenic liver abscess: a review of 10 years' experience in management" 69 : 205-209, 1999

      106 Kim KY, "Pulsed-Field Gel Electrophoresis analysis of a Salmonella london outbreak in neontes" 8 : 222-228, 2001

      107 Teasley DG, "Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile - associated diarrhoea and colitis" 2 : 1043-1046, 1983

      108 Sharma VK, "Prophylactic antibiotic administration reduces sepsis and mortality in acute necrotizing pancreatitis: a meta-analysis" 22 : 28-31, 2001

      109 Koperna T, "Prognosis and treatment of peritonitis. Do we need new scoring systems?" 131 : 180-186, 1996

      110 McFarland LV, "Prevention of beta-lactamassociated diarrhea by Saccharomyces boulardii compared with placebo" 90 : 439-448, 1995

      111 Lee SS, "Predictors of septic metastatic infection and mortality among patients with Klebsiella pneumoniae liver abscess" 47 : 642-650, 2008

      112 Grunau G, "Predictors of outcome in patients with postoperative intra-abdominal infection" 162 : 619-625, 1996

      113 Lodise TP Jr, "Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection" 51 : 3510-3515, 2007

      114 Ray P, "Predictive efficacy of nalidixic acid resistance as a marker of fluoroquinolone resistance in Salmonella enterica var Typhi" 124 : 105-108, 2006

      115 Guerrant RL, "Practice guidelines for the management of infectious diarrhea" 32 : 331-351, 2001

      116 Sitges-Serra A, "Postoperative enterococcal infection after treatment of complicated intra-abdominal sepsis" 89 : 361-367, 2002

      117 Rim MS, "Pleural empyema due to Salmonella: a case report" 15 : 138-141, 2000

      118 Ohlin B, "Piperacillin/ tazobactam compared with cefuroxime/metronidazole in the treatment of intra-abdominal infections" 165 : 875-884, 1999

      119 Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. M100-S20. Wayne, PA: CLSI"

      120 Giorgio A, "Percutaneous needle aspiration of multiple pyogenic abscesses of the liver: 13-year single-center experience" 187 : 1585-1590, 2006

      121 Akinci D, "Percutaneous drainage of 300 intraperitoneal abscesses with long-term follow-up" 28 : 744-750, 2005

      122 Grassl GA, "Pathogenesis of enteric Salmonella infections" 24 : 22-26, 2008

      123 Baron MJ, "Pancreatic infection in Mandell, Douglas, and Bennett's principles and practice of infectious diseases" Elsevier Churchill Livingston 1045-1053, 2005

      124 Longo WE, "Outcome after colectomy for Clostridium difficile colitis" 47 : 1620-1626, 2004

      125 Nalin DR, "Oral maintenance therapy for cholera in adults" 2 : 370-373, 1968

      126 Hope WW, "Optimal treatment of hepatic abscess" 74 : 178-182, 2008

      127 Wolf MK, "Occurrence, distribution, and associations of O and H serogroups, colonization factor antigens, and toxins of enterotoxigenic Escherichia coli" 10 : 569-584, 1997

      128 Johnson S, "Nosocomial Clostridium difficile colonisation and diseases" 336 : 97-100, 1990

      129 Aichinger E, "Nonutility of repeat laboratory testing for detection of Clostridium difficile by use of PCR or enzyme immunoassay" 46 : 3795-3797, 2008

      130 World Health Organization, "New formula for oral rehydration salts will save millions of lives"

      131 Sharma MP, "Needle aspiration of amoebic liver abscess" 299 : 1308-1309, 1989

      132 Snydman DR, "National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends for 1997?2000" 35 (35): S126-S134, 2002

      133 김동민, "Nalidixic acid 내성 장티푸스균에 대한 항생제 시간-살균 연구" 대한감염학회 40 (40): 207-211, 2008

      134 Shin BM, "Multicentre study of the prevalence of toxigenic Clostridium difficile in Korea: results of a retrospective study 2000-2005" 57 : 697-701, 2008

      135 Snydman DR, "Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996" 43 : 2417-2422, 1999

      136 Cueto J, "Morbidity of laparoscopic surgery for complicated appendicitis: an international study" 20 : 717-720, 2006

      137 Wain J, "Molecular typing of multiple-antibiotic-resistant Salmonella enterica serovar Typhi from Vietnam: application to acute and relapse cases of typhoid fever" 37 : 2466-2472, 1999

      138 Mikhail IA, "Microbiologic and clinical study of acute diarrhea in children in Aswan, Egypt" 21 : 59-65, 1989

      139 Fierobe L, "Methicillin-resistant Staphylococcus aureus as a causative agent of postoperative intra-abdominal infection: relation to nasal colonization" 29 : 1231-1238, 1999

      140 Trividic M, "Methi-resistant Staphylococcus aureus in dermatological practice: origin, risk factors and outcome" 129 : 27-29, 2002

      141 Szajewska H, "Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children" 25 : 257-264, 2007

      142 Lee SK, "Medical treatments of necrotizing pancreatitis" 73 : 237-242, 2007

      143 Navaneethan U, "Mechanisms of infectious diarrhea" 5 : 637-647, 2008

      144 Lee JS, "Management of acute infectious diarrhea" 50 : 600-605, 2007

      145 Pepin J, "Management and outcomes of a first recurrence of Clostridium difficile -associated disease in Quebec, Canada" 42 : 758-764, 2006

      146 Van Niel CW, "Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis" 109 : 678-684, 2002

      147 Stermer E, "Is traveler's diarrhea a significant risk factor for the development of irritable bowel syndrome? A prospective study" 43 : 898-901, 2006

      148 McPherson S, "Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea" 49 : 640-645, 2006

      149 Mazuski JE, "Intraabdominal infections" 89 : 421-437, 2009

      150 Canani RB, "Inhibitory effect of HIV-1 Tat protein on the sodium-D-glucose symporter of human intestinal epithelial cells" 20 : 5-10, 2006

      151 Gleisner AL, "Infective complications according to duration of antibiotic treatment in acute abdomen" 8 : 155-162, 2004

      152 Sifri CD, "Infections of the liver and biliary system in Mandell, Douglas, and Bennett's principles and practice of infectious diseases" Elsevier Churchill Livingston 1035-1044, 2005

      153 Pepin J, "Increasing risk of relapse after treatment Clostridium difficile colitis in Quebec, Canada" 40 : 1591-1597, 2005

      154 이경원, "Increasing Prevalence of Vancomycin-Resistant Enterococci, and Cefoxitin-, Imipenem- and Fluoroquinolone-Resistant Gram-Negative Bacilli: a KONSAR Study in 2002" 연세대학교의과대학 45 (45): 598-608, 2004

      155 Tam CC, "Incidence of Guillain-Barre syndrome among patients with Campylobacter infection: a general practice research database study" 194 : 95-97, 2006

      156 Sturkenboom MC, "Inappropriate initial treatment of secondary intra-abdominal infections leads to increased risk of clinical failure and costs" 60 : 438-443, 2005

      157 Aldridge KE, "In vitro susceptibilities of the Bacteroides fragilis group species: change in isolation rates significantly affects overall susceptibility data" 40 : 4349-4352, 2002

      158 Paterson DL, "In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intraabdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART)" 55 : 965-973, 2005

      159 Mandal S, "In vitro efficacy of ciprofloxacin alone and in combination with amoxicillin against Salmonella typhi isolates" 41 : 360-362, 2003

      160 Goldstein EJ, "In vitro activity of moxifloxacin against 923 anaerobes isolated from human intra-abdominal infections" 50 : 148-155, 2006

      161 Lennard ES, "Implications of leukocytosis and fever at conclusion of antibiotic therapy for intra-abdominal sepsis" 195 : 19-24, 1982

      162 Lamontagne F, "Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain" 245 : 267-272, 2007

      163 Chavez-Tapia NC, "Image-guided percutaneous procedure plus metronidazole versus metronidazole alone for uncomplicated amoebic liver abscess. Cochrane Database Syst Rev 2009; CD004886"

      164 Rogerson SJ, "Hydrocortisone in chloramphenicol-treated severe typhoid fever in Papua New Guinea" 85 : 113-116, 1991

      165 Lindesmith L, "Human susceptibility and resistance to Norwalk virus infection" 9 : 548-555, 2003

      166 Buchler M, "Human pancreatic tissue concentration of bactericidal antibiotics" 103 : 1902-1908, 1992

      167 Miller M, "Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality" 50 : 194-201, 2010

      168 DuPont HL, "Guidelines on acute infectious diarrhea in adults. The Practice Parameters Committee of the American College of Gastroenterology" 92 : 1962-1975, 1997

      169 Pappas PG, "Guidelines for treatment of candidiasis" Infectious Diseases Society of America 38 : 161-189, 2004

      170 Fekety R, "Guidelines for the diagnosis and management of Clostridium difficile -associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee" 92 : 739-750, 1997

      171 Infectious Diseases Society of Taiwan, "Guidelines for antimicrobial therapy of intraabdominal infections in adults" 41 : 279-281, 2008

      172 Shah N, "Global etiology of travelers' diarrhea: systematic review from 1973 to the present" 80 : 609-614, 2009

      173 Jiang ZD, "Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region" 188 : 506-511, 2003

      174 American College of Radiology Committee on Appropriateness Criteria, "Gastrointestinal imaging; right upper quadrant pain"

      175 Giannella RA, "Gastric acid barrier to ingested microorganisms in man: studies in vivo and in vitro" 13 : 251-256, 1972

      176 Marne C, "Gangrenous cholecystitis and acute cholangitis associated with anaerobic bacteria in bile" 5 : 35-39, 1986

      177 Centers for Disease Control and Prevention, "Foodborne outbreaks of enterotoxigenic Escherichia coli -Rhode Island and New Hampshire, 1993" 43 : 81-89, 1994

      178 Molla AM, "Food-based oral rehydration salt solution for acute childhood diarrhoea" 2 : 429-431, 1989

      179 Thaver D, "Fluoroquinolone for treating typhoid and paratyphoid fever (enteric fever). Cochrane Database Syst Rev 2008;CD004530"

      180 Miura F, "Flowcharts for the diagnosis and treatment of acute cholangitis and cholecystitis: Tokyo Guidelines" 14 : 27-34, 2007

      181 Harris JC, "Fecal leukocytes in diarrheal illness" 76 : 697-703, 1972

      182 Pitt HA, "Factors influencing mortality in the treatment of pyogenic hepatic abscess" 140 : 228-234, 1975

      183 Mulier S, "Factors affecting mortality in generalized post operative peritonitis: multivariate analysis in 96 patients" 27 : 379-384, 2003

      184 National Institute of Health, "Extended-spectrum β-lactamase 를 생산하는 Shigella sonnei 유행" 16 : 1-5, 2005

      185 Cheng HP, "Extended-spectrum cephalosporin compared to cefazolin for treatment of Klebsiella pneumoniae -caused liver abscess" 47 : 2088-2092, 2003

      186 DuPont HL, "Expert review of the evidence base for self-therapy of travelers' diarrhea" 16 : 161-171, 2009

      187 DuPont HL, "Expert review of the evidence base for prevention of travelers' diarrhea" 16 : 149-160, 2009

      188 Kapoor K, "Evaluation of metronidazole toxicity: a prospective study" 19 : 83-88, 1999

      189 Talan D, "Etiology of bloody diarrhea among patients presenting to United States emergency departments: prevalence of Escherichia coli O157:H7 and other enteropathogens" 32 : 573-580, 2001

      190 Su C, "Escherichia coli O157:H7 infection in humans" 123 : 698-714, 1995

      191 Griffin PM, "Escherichia coli O157:H7 and other enterohemorrhagic E. coli in Infections of the Gastrointestinal tract" Lippincott Williams & Wilkins 627-642, 2002

      192 Yoo Sunmi, "Epidemiology of Salmonella enterica Serotype Typhi Infections in Korea for Recent 9 Years: Trends of Antimicrobial Resistance" 대한의학회 19 (19): 15-20, 2004

      193 Lim HS, "Epidemiologic investigation of an outbreak of shigellosis in Kyongju, Korea" 33 : 1-9, 2000

      194 박성훈, "Enterotoxigenic Escherichia coli Outbreak in a High School" 대한감염학회 38 (38): 30-38, 2006

      195 Tielman NM, "Enteric fever and other causes of abdominal symptoms with fever in Mandell, Douglas, and Bennett's Principles and practice of infectious diseases" Churchill Livingstone Elsevier 1399-1405, 2010

      196 Seung-Hak Cho, "Enteric Bacteria Isolated from Acute Diarrheal Patients in the Republic of Korea between the Year 2004 and 2006" 한국미생물학회 46 (46): 325-330, 2008

      197 Adachi JA, "Empirical antimicrobial therapy for traveler's diarrhea" 31 : 1079-1083, 2000

      198 Shin BM, "Emerging toxin A-B+ variant strain of Clostridium difficile responsible for pseudomembranous colitis at a tertiary care hospital in Korea" 60 : 333-337, 2008

      199 Rahman M, "Emergence of multidrugresistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh" 134 : 433-438, 2006

      200 Lee K, "Emergence of multidrug-resistant Salmonella enterica serovar Typhi in Korea" 48 : 4130-4135, 2004

      201 Montravers P, "Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy" 23 : 486-494, 1996

      202 Ferreccio C, "Efficacy of ciprofloxacin in the treatment of chronic typhoid carriers" 157 : 1235-1239, 1988

      203 Ohara T, "Effects of azithromycin on shiga toxin production by Escherichia coli and subsequent host inflammatory response" 46 : 3478-3483, 2002

      204 Krobot K, "Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery" 23 : 682-687, 2004

      205 Brown KH, "Effect of continued oral feeding on clinical and nutritional outcomes of acute diarrhea in children" 112 : 191-200, 1988

      206 Sullivan A, "Effect of antimicrobial agents on the ecological balance of human microflora" 1 : 101-114, 2001

      207 Oh H, "Ecological disturbances in intestinal microflora caused by clinafloxacin, an extended-spectrum quinolone" 28 : 272-277, 2000

      208 Oh BY, "Early diagnosis of acute appendicitis by use of ultrasonography in emergency department" 9 : 586-594, 1998

      209 질병관리본부, "ESBL생성 이질균 감염증 집단 발생의 적정관리 방안"

      210 Wagner JM, "Does this patient have appendicitis?" 276 : 1589-1594, 1996

      211 Speelman P, "Differential clinical features and stool findings in shigellosis and amoebic dysentery" 81 : 549-551, 1987

      212 Raty S, "Difference in microbes contaminating pancreatic necrosis in biliary and alcoholic pancreatitis" 24 : 187-191, 1998

      213 Spruill WJ, "Diarrhea, constipation, and irritable bowel syndrome in Pharmacotherapy a pathophysiologic approach" McGraw Hill Medical 617-623, 2007

      214 Wilcox MH, "Diarrhea caused by Clostridium difficile : response time for treatment with metronidazole and vancomycin" 36 : 673-679, 1995

      215 Wada K, "Diagnostic criteria and severity assessment of acute cholangitis: Tokyo Guidelines" 14 : 52-58, 2007

      216 Dervenis C, "Diagnosis, objective assessment of severity, and management of acute pancreatitis" 25 : 195-210, 1999

      217 Gerding DN, "Diagnosis of Clostridium difficile -associated disease: patient selection and test perfection" 100 : 485-486, 1996

      218 Solomkin JS, "Diagnosis and management of complicated intraabdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America" 50 : 133-164, 2010

      219 Burnett RJ, "Definition of the role of enterococcus in intraabdominal infection: analysis of a prospective randomized trial" 118 : 716-721, 1995

      220 Lehrer RI, "Defensins: antimicrobial and cytotoxic peptides of mammalian cells" 11 : 105-128, 1993

      221 Korea Centers for Disease Control and Prevention, "Database Web Statistics System"

      222 Shin-Moo Kim, "Cytolethal Distending Toxin Production, Genotypes and Atimicrobial Susceptibility of Campylobacter jejuni Isolates from Diarrhea Patients and Chickens" 대한미생물학회 38 (38): 207-219, 2008

      223 Theisen J, "Current concepts of percutaneous abscess drainage in postoperative retention" 9 : 280-283, 2005

      224 Yun SJ, "Culture-sensitivity test and infectious complication in perforated appendicitis" 16 : 73-77, 2000

      225 Blot S, "Critical issues in the clinical management of complicated intra-abdominal infections" 65 : 1611-1620, 2005

      226 Blot S, "Critical issues in the clinical management of complicated intra-abdominal infections" 65 : 1611-1620, 2005

      227 Snydman DR, "Correlation of various in vitro testing methods with clinical outcomes in patients with Bacteroides fragilis group infections treated with cefoxitin: a retrospective analysis" 36 : 540-544, 1992

      228 Silen W, "Cope’s early diagnosis of the acute abdomen" Oxford University Press 298-, 2005

      229 Lim HS, "Contributing factors of infectious waterborne and foodborne outbreaks in Korea" 50 : 582-591, 2007

      230 Modena S, "Continuation of antibiotics is associated with failure of metronidazole for Clostridium difficile -associated diarrhea" 40 : 49-54, 2006

      231 Wenisch C, "Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile - associated diarrhea" 22 : 813-818, 1996

      232 Girgis NI, "Comparison of the efficacy, safety and cost of cefixime, ceftriaxone and aztreonam in the treatment of multidrug-resistant Salmonella typhisepticemia in children" 14 : 603-605, 1995

      233 Jin HY, "Comparison of pyogenic liver abscesses caused by Klebsiella pneumoniae and non-K. pneumoniae pathogens" 33 : 202-205, 2001

      234 Cohn SM, "Comparison of intravenous/oral ciprofloxacin plus metronidazole versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections" 232 : 254-262, 2000

      235 Mandal S, "Combination effect of ciprofloxacin and gentamicin against clinical isolates of Salmonella enterica serovar Typhi with reduced susceptibility to ciprofloxacin" 56 : 156-157, 2003

      236 변태준, "Clostridium difficile-Associated Disease (CDAD)의 최근 임상양상의 변화" 대한소화기학회 54 (54): 13-19, 2009

      237 김새희, "Clostridium difficile 관련 설사의 진단에서 S상결장경 검사의 유용성" 대한내과학회 78 (78): 318-324, 2010

      238 Samore MH, "Clostridium difficile colonization and diarrhea at a tertiary care hospital" 18 : 181-187, 1994

      239 Nair S, "Clostridium difficile colitis: factors influencing treatment failure and relapse-a prospective evaluation" 93 : 1873-1876, 1998

      240 Kelly CP, "Clostridium difficile colitis" 330 : 257-262, 1994

      241 Hookman P, "Clostridium difficile associated infection, diarrhea and colitis" 15 : 1554-1580, 2009

      242 Bartlett JG, "Clostridium difficile : clinical considerations" 12 (12): S243-S251, 1990

      243 Kelly CP, "Clostridium difficile -more difficult than ever" 359 : 1932-1940, 2008

      244 Pepin J, "Clostridium difficile -associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity" 171 : 466-472, 2004

      245 Oh YJ, "Clinical study of liver abscess" 18 : 13-22, 1976

      246 Calandra T, "Clinical significance of Candida isolated from peritoneum in surgical patients" 2 : 1437-1440, 1989

      247 Crump JA, "Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort study" 52 : 1278-1284, 2008

      248 Bartlett JG, "Clinical recognition and diagnosis of Clostridium difficile infection" 46 (46): S12-S18, 2008

      249 DuPont HL, "Clinical practice: bacterial diarrhea" 361 : 1560-1569, 2009

      250 Bartlett JG, "Clinical practice. Antibiotic-associated diarrhea" 346 : 334-339, 2002

      251 Thielman NM, "Clinical practice. Acute infectious diarrhea" 350 : 38-47, 2004

      252 Strasberg SM, "Clinical practice. Acute calculous cholecystitis" 358 : 2804-2811, 2008

      253 Cohen SH, "Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA)" 31 : 431-455, 2010

      254 Bouza E, "Clinical manifestations, treatment and control of infections caused by Clostridium difficile" 11 (11): 57-64, 2005

      255 Kang CI, "Clinical features and outcome of community-onset bloodstream infections caused by extended-spectrum betalactamase-producing Escherichia coli" 27 : 85-88, 2008

      256 Lee SB, "Clinical characteristics and prognostic factors of bacteremia and sepsis" 56 : 347-358, 1999

      257 Montravers P, "Clinical and therapeutic features of nonpostoperative nosocomial intra-abdominal infections" 239 : 409-416, 2004

      258 Montravers P, "Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA study" 63 : 785-794, 2009

      259 Threlfall EJ, "Ciprofloxacin-resistant Salmonella typhi and treatment failure" 353 : 1590-1591, 1999

      260 이광선, "Ciprofloxacin 치료에 실패한 국내에서감염된 장티푸스 1예" 대한감염학회 40 (40): 175-178, 2008

      261 박재은, "Ciprofloxacin 치료에 반응이 없는 유입된 장티푸스 1예" 대한감염학회 49 (49): 46-49, 2007

      262 Swenson BR, "Choosing antibiotics for intra-abdominal infections: what do we mean by “high risk”?" 10 : 29-39, 2009

      263 Shogomori H, "Cholera toxin is found in detergent-insoluble rafts/domains at the cell surface of hippocampal neurons but is internalized via a raft-independent mechanism" 276 : 9182-9188, 2001

      264 Munoz C, "Characteristics of Shigella sonnei infection of volunteers: signs, symptoms, immune responses, changes in selected cytokines and acutephase substances" 53 : 47-54, 1995

      265 Dutta P, "Ceftriaxone therapy in ciprofloxacin treatment failure typhoid fever in children" 113 : 210-213, 2001

      266 Montravers P, "Candida as a risk factor for mortality in peritonitis" 34 : 646-652, 2006

      267 Hedrick TL, "Can we define the ideal duration of antibiotic therapy?" 7 : 419-432, 2006

      268 Skirrow MB, "Campylobacter jejuni in Infections of the gastrointestinal tract" Raven Press 825-848, 1995

      269 Hickey TE, "Campylobacter jejuni cytolethal distending toxin mediates release of interleukin-8 from intestinal epithelial cells" 68 : 6535-6541, 2000

      270 Betsch A, "CT-guided percutaneous drainage of intra-abdominal abscesses: APACHE III score stratification of 1-year results. Acute physiology, age, chronic health evaluation" 12 : 2883-2889, 2002

      271 Pinto Leite N, "CT evaluation of appendicitis and its complications: imaging techniques and key diagnostic findings" 185 : 406-417, 2005

      272 McFarland LV, "Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease" 97 : 1769-1775, 2002

      273 De Waele JJ, "Blood stream infections of abdominal origin in the intensive care unit: characteristics and determinants of death" 9 : 171-177, 2008

      274 Sung IK, "Bacteriological study of bile in patients with cholangitis due to biliary tract obstruction" 55 : 28-32, 1998

      275 Neuschwander-Tetri BA, "Bacterial, parasitic, fungal, and granulomatous liver diseases in Cecil Medicine" Saunders 1128-1135, 2007

      276 Effa EE, "Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever). Cochrane Database Syst Rev 2008;CD006083"

      277 Kyne L, "Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea" 357 : 189-193, 2001

      278 Mazuski JE, "Antimicrobial treatment for intra-abdominal infections" 8 : 2933-2945, 2007

      279 Laterre PF, "Antimicrobial therapy for intra-abdominal infections: guidelines from the Infectious Disease Advisory Board (IDAB)" 106 : 2-21, 2006

      280 Tanaka A, "Antimicrobial therapy for acute cholangitis: Tokyo Guidelines" 14 : 59-67, 2007

      281 WHO network on antimicrobial resistance monitoring: Korean focal and core laboratory, "Antimicrobial resistance newsletter"

      282 Dougherty SH, "Antimicrobial culture and susceptibility testing has little value for routine management of secondary bacterial peritonitis" 25 (25): S258-S261, 1997

      283 Bartlett JG, "Antibiotic-associated diarrhea" 15 : 573-581, 1992

      284 Hyun Joo Song, "Antibiotic-Associated Diarrhea: Candidate Organisms other than Clostridium Difficile" 대한내과학회 23 (23): 9-15, 2008

      285 Mosdell DM, "Antibiotic treatment for surgical peritonitis" 214 : 543-549, 1991

      286 Nelson R, "Antibiotic treatment for Clostridium difficile -associated diarrhea in adults. Cochrane Database Syst Rev 2007;CD004610"

      287 Villatoro E, "Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev 2006;CD002941"

      288 Rojo D, "Analysis of risk factors associated with nosocomial bacteraemias" 42 : 135-141, 1999

      289 Joo HJ, "An outbreak of Yersinia pseudotuberculosis infection" 33 : 342-350, 1990

      290 Jin SM, "An epidemiological survey on the outbreak of cholera of overseas travelers in Daejeon" 28 : 119-128, 2006

      291 Shin HR, "An epidemiologic investigation of typhoid fever outbreak in Pusan, 1996" 19 : 122-130, 1997

      292 Tan YM, "An appraisal of surgical and percutaneous drainage for pyogenic liver abscesses larger than 5 cm" 241 : 485-490, 2005

      293 Stanley SL Jr, "Amoebiasis" 361 : 1025-1034, 2003

      294 Weinke T, "Amebic liver abscess-rare need for percutaneous treatment modalities" 7 : 25-29, 2002

      295 Miller RA, "Amebiasis, giardiasis, and other intestinal protozoal infections in The travel & tropical medicine manual" WB Saunders 325-341, 1995

      296 Aucott JN, "Amebiasis and "nonpathogenic" intestinal protozoa" 7 : 467-485, 1993

      297 Aucott JN, "Amebiasis and "nonpathogenic" intestinal protozoa" 7 : 467-485, 1993

      298 Haque R, "Amebiasis" 348 : 1565-1573, 2003

      299 Shin BM, "Algorithm combining toxin immunoassay and stool culture for diagnosis of Clostridium difficile infection" 47 : 2952-2956, 2009

      300 Apisarnthanarak A, "Adjunctive intracolonic vancomycin for severe Clostridium difficile colitis: case series and review of the literature" 35 : 690-696, 2002

      301 Pai H, "Acute infectious diarrhea" 73 : 114-118, 2007

      302 American College of Radiology Committee on Appropriateness Criteria®, "Acute abdominal pain and fever or suspected abdominal abscess"

      303 Klevens RM, "Active Bacterial Core surveillance (ABCs) MRSA Invasive methicillinresistant Staphylococcus aureus infections in the United States" 298 : 1763-1771, 2007

      304 American Gastroenterological Association (AGA) Institute on "Management of Acute Pancreatits" Clinical Practice and Economics Committee, "AGA Institute medical position statement on acute pancreatitis" 132 : 2019-2021, 2007

      305 Rodrigue DC, "A university outbreak of Escherichia coli O157:H7 infections associated with roast beef and an unusually benign clinical course" 172 : 1122-1125, 1995

      306 DuPont HL, "A randomized, doubleblind, placebo controlled trial of rifaximin to prevent travelers' diarrhea" 142 : 805-812, 2005

      307 Chinh NT, "A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever" 44 : 1855-1859, 2000

      308 Loo VG, "A predominantly clonal multiinstitutional outbreak of Clostridium difficile -associated diarrhea with high morbidity and mortality" 353 : 2442-2449, 2005

      309 Mohamed JA, "A novel single-nucleotide polymorphism in the lactoferrin gene is associated with susceptibility to diarrhea in North American travelers to Mexico" 44 : 945-952, 2007

      310 OOliva ME, "A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intraabdominal infections" 5 : 88-, 2005

      311 Zar FA, "A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile -associated diarrhea, stratified by disease severity" 45 : 302-307, 2007

      312 Thaver D, "A comparison of fluoroquinolones versus other antibiotics for treating enteric fever: meta-analysis" 338 : b1865-, 2009

      313 Jiang ZD, "A common polymorphism in the interleukin 8 gene promoter is associated with Clostridium difficile diarrhea" 101 : 1112-1116, 2006

      314 Bradley EL 3rd, "A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992" 128 : 586-590, 1993

      315 Lee OJ, "A clinical study on liver abscess" 26 : 506-520, 1994

      316 Kim SB, "A clinical study on liver abscess" 43 : 691-698, 1992

      317 Ahn BY, "A clinical analysis of acaluclous cholecystitis" 53 : 579-587, 1997

      318 Han BH, "A case of typhoid fever complicated with pleurisy and hepatitis" 65 (65): S717-S720, 2003

      319 Lee JD, "A case of icteric typhoid hepatitis complicated with splenic infarction" 35 : 801-805, 2000

      320 Wang HH, "A blind, randomized comparison of racecadotril and loperamide for stopping acute diarrhea in adults" 11 : 1540-1543, 2005

      321 홍석경, "3차 대학병원 내과계 중환자실 내 중증 패혈증의 유병률과 예후인자" 대한중환자의학회 24 (24): 28-32, 2009

      322 임현술, "2004년 영천시 D 초등학교에서 집단 발생한 살모넬라증" 대한예방의학회 38 (38): 457-464, 2005

      323 Shukla S, "100 years of Widal test and its reappraisal in an endemic area" 105 : 53-57, 1997

      324 Duggan C, ""Feeding the gut": the scientific basis for continued enteral nutrition during acute diarrhea" 131 : 801-808, 1997

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2011-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2010-02-25 학술지명변경 한글명 : 감염과화학요법 -> Infection and Chemotherapy
      외국어명 : Infection and Chemotherapy -> 미등록
      KCI등재후보
      2010-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2009-08-25 학술지명변경 외국어명 : 미등록 -> Infection and Chemotherapy KCI등재후보
      2008-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      2008-01-01 평가 등재후보 탈락 (등재후보1차)
      2006-01-01 평가 등재후보 1차 FAIL (등재후보2차) KCI등재후보
      2005-05-27 학술지등록 한글명 : 감염과화학요법
      외국어명 : 미등록
      KCI등재후보
      2005-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2004-01-01 평가 등재후보 1차 FAIL (등재후보1차) KCI등재후보
      2002-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.24 0.24 0.24
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.2 0.2 0.46 0.29
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼